Objectives To determine a highly specific liver attenuation threshold at unenhanced CT for
biopsy-proven moderate to severe hepatic steatosis (≥ 30% at histology). Methods 315 …

OBJECTIVE. The purpose of this study was to investigate the prevalence of hepatic steatosis
in an asymptomatic US adult population using attenuation values at unenhanced CT as the …

Purpose To establish the reference range for hepatic attenuation minus splenic attenuation
difference (CTL− S) values on nonenhanced computed tomographic (CT) images obtained …

The noninvasive diagnosis of hepatic steatosis is of increasing concern. This study
investigated the association of hepatic steatosis determined by non-enhanced CT criteria …

OBJECTIVE. Hepatic steatosis is a common incidental finding at radiologic imaging. The
natural history of nonalcoholic fatty liver disease (NAFLD) and its associated risks for …

Background Nonalcoholic fatty liver disease and its consequences are a growing public
health concern requiring cross-sectional imaging for noninvasive diagnosis and …

Objectives To investigate the diagnostic performance of attenuation imaging (ATI) for the
assessment of low-grade hepatic steatosis using liver biopsy as the reference standard …

Purpose: To retrospectively compare the accuracy of visual grading and the liver attenuation
index in the computed tomographic (CT) diagnosis of 30% or higher macrovesicular …

Purpose The present study compared the performance of computed tomography (CT),
magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF), controlled …

Objectives To prospectively assess the role of the US attenuation imaging coefficient (AC)
for the diagnosis and quantification of hepatic steatosis. Methods One hundred and one …